Newton, MA, United States of America

Blaise S Lippa

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 11.4

ph-index = 5

Forward Citations = 52(Granted Patents)


Location History:

  • Acton, MA (US) (2013 - 2016)
  • Concord, MA (US) (2019 - 2020)
  • Newton, MA (US) (2021 - 2023)

Company Filing History:


Years Active: 2013-2025

where 'Filed Patents' based on already Granted Patents

20 patents (USPTO):

Title: **Blaise S. Lippa: Innovator in Integrin Research**

Introduction

Blaise S. Lippa is a prominent inventor based in Newton, MA, who has made significant contributions to the field of integrin research. With an impressive portfolio of 18 patents, Lippa's work primarily focuses on developing small molecule antagonists and inhibitors that target specific integrins, paving the way for new therapeutic treatments for various diseases.

Latest Patents

Among his latest patents, Lippa has developed small molecule antagonists of human integrin α4β7, which are disclosed as potentially effective methods for treating numerous diseases and conditions. Additionally, he has also patented inhibitors of the αvβ6 integrin, which encompass methods for treating various health issues. These innovations reflect Lippa's commitment to advancing medical science through targeted integrin modulation.

Career Highlights

Throughout his career, Blaise S. Lippa has worked with reputable companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Morphic Therapeutics, Inc., where he contributed to groundbreaking research and development. He also held a position at Cubist Pharmaceuticals Incorporated, further establishing his expertise in the field.

Collaborations

Lippa's work is enhanced by collaborations with talented colleagues, including Bryce Alden Harrison and Matthew Gregory Bursavich. These partnerships in research and development underscore the importance of teamwork and shared vision in driving innovation within the pharmaceutical industry.

Conclusion

Blaise S. Lippa exemplifies the spirit of innovation in the biomedical field, particularly through his impactful patents targeting integrins. His contributions not only highlight his expertise but also pave the way for future advancements in treatment methodologies. The interplay of his collaborations and career experiences continues to shape the landscape of integrin research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…